| Product Code: ETC7312393 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Parkinsons Disease Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Germany Parkinsons Disease Market - Industry Life Cycle |
3.4 Germany Parkinsons Disease Market - Porter's Five Forces |
3.5 Germany Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Germany Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Germany Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Germany Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Germany Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Germany Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Germany |
4.2.2 Technological advancements in treatment options |
4.2.3 Growing awareness and focus on early diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High treatment costs and limited insurance coverage |
4.3.2 Side effects associated with current therapies |
4.3.3 Limited accessibility to specialized healthcare facilities in rural areas |
5 Germany Parkinsons Disease Market Trends |
6 Germany Parkinsons Disease Market, By Types |
6.1 Germany Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Germany Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Germany Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Germany Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Germany Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Germany Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Germany Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Germany Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Germany Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Germany Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Germany Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Germany Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Germany Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Germany Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Germany Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Germany Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Germany Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Germany Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Germany Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Germany Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Germany Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Germany Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Germany Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Germany Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Germany Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Germany Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Germany Parkinsons Disease Market Export to Major Countries |
7.2 Germany Parkinsons Disease Market Imports from Major Countries |
8 Germany Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis of Parkinson's disease in Germany |
8.2 Number of clinical trials for Parkinson's disease treatments in Germany |
8.3 Adoption rate of telemedicine solutions for Parkinson's disease management |
8.4 Patient satisfaction with Parkinson's disease healthcare services |
8.5 Percentage of Parkinson's disease patients receiving multidisciplinary care |
9 Germany Parkinsons Disease Market - Opportunity Assessment |
9.1 Germany Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Germany Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Germany Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Germany Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Germany Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Germany Parkinsons Disease Market - Competitive Landscape |
10.1 Germany Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Germany Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here